Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?
2013/6/3
Journal of Clinical Oncology (JCO) Podcast
Frequently requested episodes will be transcribed first
Shownotes Transcript
Minimal residual disease predicts outcomes in myeloma.